Cabozantinib N-oxide | CAS 1621681-63-7 - Request Quote
Cabozantinib N-oxide
| SZ CAT No: | SZ-C112008 |
| CAS No | 1621681-63-7 |
| Mol.F. | C28H24FN3O6 |
| Mol.Wt. | 517.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib N-oxide is chemically 4-(4-(1-((4-Fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide. Cabozantinib N-oxide is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib N-oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1621681-63-7
Purchase 1621681-63-7
Order 1621681-63-7
Enquire 1621681-63-7
price of 1621681-63-7
1621681-63-7 Supplier
1621681-63-7 Manufacturer
1621681-63-7 Exporter
buy high quality Cabozantinib N-oxide
Purchase Cabozantinib N-oxide
Cabozantinib N-oxide suppliers
Cabozantinib N-oxide manufacturers
Cabozantinib N-oxide price
Order Cabozantinib N-oxide
Enquire Cabozantinib N-oxide
Cabozantinib N-oxide cost
Cabozantinib N-oxide Supplier
Cabozantinib N-oxide Distributor
Cabozantinib N-oxide for Method Validation
Cabozantinib Reference Standard
Cabozantinib N-oxide for ANDA Filing
Cabozantinib N-oxide for Forced Degradation Studies
Cabozantinib N-oxide Identification Standards
Cabozantinib N-oxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.